Moteur de recherche d’entreprises européennes
Registre de Transparence de l'Union Européenne Eutr 29/11/2025 Registre de Transparence de l'Union Européenne
Vue d’ensemble
Texte
EU Transparency Register Entry
Identification
- Identification Code: 790576352506-25
- Registration Date: 2024-01-17 05:39:51
- Last Update Date: 2025-11-27 10:16:00
General Information
- Name: SEQENS
- Entity Form: Société par Actions Simplifiée
- Website: www.seqens.com
- Registration Category: Companies & groups
- Interest Represented: Promotes their own interests or the collective interests of their members
Contact Information
Head Office
- Address: 21 chemin de la Sauvegarde, 69130 Ecully, FRANCE
- Phone: +33 0426991800
EU Office
- Address: 21 chemin de la Sauvegarde, 69130 Ecully, FRANCE
- Phone: +33 0426991800
Goals
SEQENS is a world leader in the development and production of active pharmaceutical ingredients, intermediates and specialty ingredients, with 16 production sites, 9 R&D centers and 3,000 employees on 3 continents. As an integrated player across the entire value chain - from raw materials to active ingredients and from R&D to industrialization - SEQENS offers a broad portfolio of active pharmaceutical ingredients, pharmaceutical intermediates and specialty ingredients, develops and industrializes the most complex molecules, and leverages its ability to innovate, develop and implement the best available technologies.
Levels of Interest
- Global
EU Legislative Proposals and Communication Activities
- EU Legislative Proposals: EU Pharmaceutical Legislation, EU Pharmaceutical Strategy, Critical Medicines Alliance, Electricity Market Design, EU-ETS
- Communication Activities: Member of the Critical Medicines Alliance (https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en), Participation to JICF, Member of the Critical Chemicals Alliance
- Inter or Unofficial Groupings: N/A
Members
- Members (25%):
? - Members (Total): 1.0
- Members (FTE): 0.25
- Information on Members:
European Parliament Accreditation
- Accredited Number: 0
Interests
- Competition
- Energy
- Environment
- Public health
Structure
- Is Member Of: Cf. ci-dessus
- Organisation Members:
- CEFIC (https://cefic.org/)
- France Chimie (https://www.francechimie.fr/)
- EFCG (https://efcg.cefic.org/)
- SICOS (https://chimiefine-biochimie.fr/Le-SICOS-Biochimie)
- UNIDEN (https://www.uniden.fr/)
- MEDEF (https://www.medef.com/fr/)
Financial Data
- New Organisation: No
Closed Year (2024-01-01 to 2024-12-01)
- Costs: €10,000 - €24,999
- Grants: Not specified
Current Year
- Intermediaries: Not specified
- Grants: Not specified
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Seqens SAS, Écully.